Searching map area
Linda-Gail Bekker
? TBD
Zimbabwean physician & academic
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Works 6
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
scientific article published on February 20, 2014
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
scientific article
Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole
scientific article published on 25 May 2007
Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern
publication published on 10 February 2022
How Many Interviews Are Enough?
scientific article published on 02 January 2021
Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa
scientific article published on August 2009
Lists 0
Join to rate
Wikipedia

Linda-Gail Bekker MBChB, DTMH, DCH, FCP(SA) is a professor of Medicine and Chief Executive Officer of the Desmond Tutu Health Foundation. She is also Director of the Desmond Tutu HIV Centre at the University of Cape Town. She is a Past President of the International AIDS Society (2016–18).

Elsewhere
Instance of
Human
Occupation
Physician
university teacher
HIV/AIDS activist
References
Wikidata